SCHEMBL25661302

SCHEMBL25661302

c1ccc2c(c1)oc1c(-c3ccc(-c4nc(-n5c6ccccc6c6ccccc65)nc(-n5c6ccccc6c6ccccc65)n4)cc3)cccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.48
▸ PRKDC P78527 7/20 0.40
▸ PIK3CD O00329 3/20 0.40
▸ PIK3CB P42338 2/20 0.40
▸ DRD4 P21917 1/20 0.37
▸ GGPS1 O95749 1/20 0.37
▸ MAPT P10636 4/20 0.36
▸ TSHR P16473 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ LMNA P02545 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25661349 0.99 ALOX5 (0.47) ALOX5PRKDCPIK3CDPIK3CBDRD4
SCHEMBL21964932 0.95 ALOX5 (0.46) ALOX5PRKDCPIK3CDPIK3CBDRD4
SCHEMBL22737979 0.93 ALOX5 (0.44) ALOX5PRKDCPIK3CDPIK3CBDRD4
SCHEMBL24943502 0.92 ALOX5 (0.43) ALOX5PRKDCPIK3CDPIK3CBDRD4
SCHEMBL25661326 0.92 ALOX5 (0.46) ALOX5PRKDCPIK3CDPIK3CBGGPS1
SCHEMBL25661335 0.92 ALOX5 (0.49) ALOX5PRKDCPIK3CDPIK3CBDRD4
SCHEMBL16810969 0.91 ALOX5 (0.42) ALOX5PRKDCPIK3CDPIK3CBDRD4
SCHEMBL16810896 0.91 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBDRD4
SCHEMBL25661611 0.91 ALOX5 (0.44) ALOX5PRKDCPIK3CDPIK3CBGGPS1
SCHEMBL25661691 0.91 ALOX5 (0.44) ALOX5PRKDCPIK3CDPIK3CBGGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-05-18 — — US disclosed
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER CYP1B1, NOTUM, ORMDL3 ALOX5 213/4885PRKDC 4246/4885PIK3CD 3239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback